ABCB5 and non-small cell lung carcinoma: hsa-miR-522-3p has been shown to be upregulated in some cancers such as glioblastoma and non-small cell lung cancer.22,23 It has been reported that this miRNA reverses drug resistance of doxorubicin-induced HT29 colon cancer cell by targeting ABCB5.